Kintor Pharma-B Sees Shareholding Increase by KT Corp's Investment Arm
Deep News
Jul 22
Recent data from the Hong Kong Stock Exchange reveals a share purchase in Kintor Pharma-B (09939) by KT International Investment Limited.
The transaction, executed on July 17th, involved the acquisition of 145,000 shares at a price of HK$1.713 per share.
The total consideration for this purchase amounted to approximately HK$248,400.
Following this transaction, the latest shareholding of KT International Investment Limited stands at approximately 55.5078 million shares.
This represents a stake of about 11.13% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.